Virtual Library

Start Your Search

  • ELCC 2017

    The 7th European Lung Cancer Conference

    Access to all presentations that took place at ELCC 2017 in Geneva, Switzerland

    Presentation Date(s):  
    • May 5 – 8, 2017
    • Total Presentations: 359

Filter Results:

Show Only Available Presentations

  • +

    Immunotherapy for other thoracic tumours

    • Type: Educational session
    • Presentations: 5
    • Moderators:S. Popat
    • Coordinates: 5/06/2017, 09:00 - 10:30, Room B
    • +

      Perspectives in SCLC

      09:00 - 09:20  |  Author(s): S. Peters

      • Abstract

      No abstract available for this presentation

    • +

      Realities in mesothelioma

      09:20 - 09:40  |  Author(s): S. Popat

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Thymic tumours

      09:40 - 10:00  |  Author(s): G. Giaccone

      • Abstract

      No abstract available for this presentation

    • +

      T cell therapies

      10:00 - 10:20  |  Author(s): A. Dingemans

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Questions and Answers

      10:20 - 10:30

      • Abstract

      No abstract available for this presentation

  • +

    Epidemiology and innovations in biomarker development

    • Type: Poster Discussion session
    • Presentations: 12
    • Moderators:P. Boffetta
    • Coordinates: 5/06/2017, 16:45 - 17:45, Room W
    • +

      95PD - Diagnostic EGFR testing with ctDNA versus tumour in patients with advanced non-small cell lung cancer (NSCLC): The Royal Marsden experience

      16:45 - 16:45  |  Author(s): R. Kumar

      • Abstract

      Loading...

  • +

    Targeted therapies and management of brain metastasis

    • Type: Proffered Paper session
    • Presentations: 7
    • Moderators:D.P. Carbone
    • Coordinates: 5/06/2017, 16:45 - 18:15, Room A
  • +

    SCLC and early stage NSCLC

    • Type: Proffered Paper session
    • Presentations: 7
    • Moderators:S. Popat
    • Coordinates: 5/07/2017, 09:00 - 10:30, Room C
    • +

      44O - Validation of the prognostic value of 8th edition revisions of the AJCC staging system for non-small cell lung cancer: A SEER database analysis

      09:00 - 09:12  |  Author(s): O. Abdel-Rahman

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      59O - The impact of EGFR mutations on the prognosis of resected non-small cell lung cancer: A meta-analysis of literatures

      09:12 - 09:24  |  Author(s): W. Liang

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      60O - The benchmark of examined lymph node count in node positive NSCLC patients: A populational validation with SEER database

      09:24 - 09:36  |  Author(s): W. Liang

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Invited Discussant 44O, 59O and 60O

      09:36 - 09:51  |  Author(s): W.E.E. Eberhardt

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      51O - Early limited-stage small cell lung cancer: Sub-group analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) trial

      09:51 - 10:03  |  Author(s): A. Salem

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      LBA2_PR - Use of G-CSF and prophylactic antibiotics with concurrent chemo-radiotherapy in limited-stage small cell lung cancer: Results from the Phase III CONVERT trial

      10:03 - 10:15  |  Author(s): F. Gomes

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Invited Discussant 51O and LBA2_PR

      10:15 - 10:30  |  Author(s): S. Popat

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    Poster Display Session

    • Type: Poster Display Session
    • Presentations: 142
    • Coordinates: 5/07/2017, 12:30 - 13:00, Hall 1
    • +

      170TiP - LUME-Meso: Randomised phase II/III study of nintedanib (N) + pemetrexed/cisplatin (PEM/CIS) followed by maintenance N or placebo (P) in chemo-naïve patients with malignant pleural mesothelioma (MPM)

      12:30 - 12:30  |  Author(s): S. Popat

      • Abstract

      Loading...